Peptides for anxiety, focus and brain fog: Semax, Selank and more

Anxiety is excess worry and arousal. Attention problems are a failure of executive function: sustaining focus, holding things in working memory, starting tasks. Brain fog is a subjective slowing of thought that is almost always secondary to something else, most often poor sleep, depression, thyroid, iron, illness, perimenopause or medication. Selank is the anxiety one. Semax is the attention one, and its page lists restlessness and irritability as side effects, so it can make anxiety worse. Selank in turn can leave some people flat.

For brain fog, neither is a first move. The fix is the cause, and a blood panel and a sleep history find most causes. A diagnosed anxiety disorder or ADHD has treatments with large trials behind them, and the Selank page is explicit that it is not a substitute for treatment of a diagnosed anxiety disorder. Where these peptides fit is the gap below diagnosis: a stressful stretch or a demanding work period.

Semax is a seven amino acid peptide built from the 4-10 fragment of ACTH with a Pro-Gly-Pro tail for stability. That fragment does not stimulate cortisol. It was developed at the Institute of Molecular Genetics in Moscow and has been a Russian prescription medicine since the mid 1990s: a 0.1 percent nasal solution for cognitive complaints and a 1 percent solution for acute ischemic stroke. In rodents it raises BDNF and its TrkB receptor in the hippocampus within hours of a nasal dose and protects neurons during ischemia.

The human evidence is a fairly large Russian clinical literature of open label and small controlled studies. They report faster neurological recovery after stroke and better attention and memory task performance in healthy volunteers after a single nasal dose. The methodology is weaker than Western regulators expect, and there is essentially no independent double blind replication. The anxiety data is rodent only. Side effects are nasal irritation, dryness and occasional nosebleeds, restlessness or irritability at higher doses, trouble sleeping when dosed late, and hair thinning reported anecdotally by a minority of long term users.

Selank is tuftsin, a four amino acid immune peptide, with the same Pro-Gly-Pro tail, developed by the same lab and registered in Russia in 2009 as a nasal drop for generalized anxiety disorder and neurasthenia. The most cited trial compared it to the benzodiazepine phenazepam and found comparable anxiety reduction with fewer sedative effects, plus improvement in concentration and memory complaints as secondary findings. These are real trials, but small, some open label, and none replicated outside Russia.

Rodent studies show Selank changes expression of GABA receptor and transport genes and enhances GABA's effect on chloride currents in a way that suggests allosteric modulation, without binding the benzodiazepine site. It also slows enkephalin breakdown. No dependence or withdrawal has been reported, and the effects fade within about a week of stopping. Side effects are fatigue or emotional flatness at higher doses, nasal irritation, and for a fair share of users no noticeable effect at all. The caution that matters is adding it to benzodiazepines or other sedatives.

Pinealon is the tripeptide Glu-Asp-Arg from Vladimir Khavinson's bioregulator group in St. Petersburg, sold in Russia as a capsule supplement for older adults with cognitive complaints. In cell culture it lowers free radical levels and improves neuron survival under oxidative stress; in rats it reduced deficits from prenatal hyperhomocysteinemia and improved learning in aged animals. The human data is small open label studies in elderly Russian patients reporting better cognitive scores. It is low risk and low evidence, and its page says many users notice nothing.

It appears here as a background compound run alongside a Semax course rather than as a treatment for anything. Community injected doses are 1 to 5 mg daily for 10 to 20 days, once or twice a year, while the Russian oral capsules contain far less peptide, so the two routes are not interchangeable.

The Russian products are drops, and the community numbers derive from them. Semax 0.1 percent delivers roughly 50 mcg per drop, so two to three drops per nostril is about 200 to 300 mcg, the low end of the 200 to 600 mcg range that circulates. Selank 0.15 percent delivers roughly 75 mcg per drop, and two to three drops per nostril gives about 300 to 450 mcg inside the 250 to 750 mcg range. The compound pages report Semax at 200 to 300 mcg once or twice daily for everyday focus and 300 to 600 mcg two to three times daily for a full course. Selank runs 250 to 500 mcg two to three times daily for baseline anxiety or as a single dose before a stressful event, with 750 mcg as a higher trial that some find tiring.

People who buy powder make their own spray. A 5 mg vial in 2 mL of bacteriostatic water is 2.5 mg per mL, and a typical metered pump delivering 0.1 mL per spray gives 250 mcg per spray; the calculator and reconstitution guide adjust for other pumps and vials. Semax goes in the morning or early afternoon, since late doses disturb sleep; Selank any time, often 20 to 30 minutes ahead of whatever it is for. Mixed solutions live in the fridge for four weeks, and a cheap ready made spray of unknown age may be nearly inert.

The course structure exists because of tolerance. The Semax page reports that the alerting effect fades with continuous daily use, which is why protocols run 10 to 20 days and then break for a similar stretch. The initial buzz usually plateaus by week two to three, and effects taper over a week or two after stopping with no withdrawal. Selank runs two to three weeks with a one to three week break, or is used on specific days instead, and its effects fade within about a week with no rebound anxiety reported.

What people describe is consistent with the mechanisms and modest in size. Semax: alertness within 15 to 30 minutes of a nasal dose, sometimes with an edge, then steadier focus and often a mood lift over one to two weeks, which is where most people decide whether it works. Selank: a subtle calm and a clearer head within half an hour, or nothing; easier sleep onset when worry was the cause. The common pairing is Semax in the morning for drive and Selank later for calm, which the Semax and Selank stack page lays out, with DSIP sometimes added at night when anxiety disrupts sleep.

Interactions worth knowing: caffeine and ADHD stimulants add restlessness and insomnia to Semax. SSRIs and other serotonergic drugs are a caution for both, on rodent serotonin data with no human interaction data. Benzodiazepines and alcohol are GABA leaning and can leave Selank users flat and tired.

For anxiety, cognitive behavioral therapy and SSRIs or SNRIs have large trials. For attention disorders, stimulant and non-stimulant medications do. For brain fog, sleep, thyroid and iron labs, exercise and a look at the medication list solve most cases. One unexpected entry belongs here. Tesamorelin, a growth hormone releasing hormone analog, improved executive function scores over 20 weeks in a randomized trial of older adults with and without mild cognitive impairment. That is a better trial than anything behind Semax, though it has not been replicated at scale and brings the growth hormone class cautions with it. Best peptides for sleep covers the sleep side.

Peptide cycling covers the on and off structure in general, and peptides for beginners covers the sourcing and evidence questions that apply to a Russian prescription product bought as a research powder.